Open AccessA DRB (5,6 dichloro-β-D-ribofuranosyIbenzimidazole)-resistant adenovirus mRNA
Author(s) -
Björn Vennström,
Hikan Persson,
Ulf Pettersson,
Lennart Philipson
Publication year - 1979
Publication title -
nucleic acids research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 9.008
H-Index - 537
eISSN - 1362-4954
pISSN - 0305-1048
DOI - 10.1093/nar/7.6.1405
Subject(s) - biology , microbiology and biotechnology , transcription (linguistics) , messenger rna , rna polymerase ii , polymerase , virology , dna , promoter , gene , gene expression , genetics , philosophy , linguistics
5,6-Dichloro-beta-D ribofuranosyl benzimidazole (DRB) inhibits transcription from the major late adenovirus promoter, located on the r-strand at map position 16.3 on the viral genome. 100-500 nucleotides long RNA chains with capped 5'-termini are transcribed from this promoter in the presence of 70 muM DRB. Synthesis of the mRNA for polypeptide IX which is unspliced and maps on the r-strand between positions 9.7 and 10.9 appears, however, to be DRB-resistant although it is transcribed by polymerase II and capped. Translatable mRNA for polypeptide IX is synthesized in the presence of DRB while the mRNAs for the other viral structural proteins are not synthesized. This differential DRB-inhibition of polymerase II transcription suggests either that short mRNAs may escape inhibition or that unspliced mRNAs are insensitive to the drug.